These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 15736410

  • 1. Head and neck squamous cell carcinoma cell lines are highly sensitive to the new taxanes, BMS-184476, BMS-188797, in vitro.
    Raitanen M, Pulkkinen J, Kulmala J, Grénman R.
    Anticancer Res; 2004; 24(6):3769-73. PubMed ID: 15736410
    [Abstract] [Full Text] [Related]

  • 2. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
    Erjala K, Pulkkinen J, Kulmala J, Alanen K, Grenman R.
    Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
    [Abstract] [Full Text] [Related]

  • 3. Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.
    Erjala K, Raitanen M, Kulmala J, Grénman R.
    Anticancer Res; 2005; 25(6B):4363-7. PubMed ID: 16309241
    [Abstract] [Full Text] [Related]

  • 4. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.
    Erjala K, Raitanen M, Kulmala J, Grénman R.
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904
    [Abstract] [Full Text] [Related]

  • 5. Taxanes in cancer of the head and neck.
    Misiukiewicz K, Gupta V, Bakst R, Posner M.
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [Abstract] [Full Text] [Related]

  • 6. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
    Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R.
    Anticancer Res; 1997 May; 17(2A):939-43. PubMed ID: 9137431
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer.
    Pulkkinen JO, Elomaa L, Joensuu H, Martikainen P, Servomaa K, Grenman R.
    J Cancer Res Clin Oncol; 1996 May; 122(4):214-8. PubMed ID: 8601573
    [Abstract] [Full Text] [Related]

  • 8. BMS-275183-induced gene expression patterns in head and neck carcinoma.
    Yoo GH, Tran VR, Lemonnier LA, Ezzat WH, Subramanian G, Piechocki MP, Ensley JF, Lonardo F, Kim H, Lin HS.
    Am J Otolaryngol; 2007 May; 28(5):309-15. PubMed ID: 17826531
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.
    Steinberg L, Hassan M, Olmsted L, Sharan V, Stepnick D, Hoppel C, Mugharbil A, Subramanyan S, McGloin B, Mackay W, Strauss M.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267
    [Abstract] [Full Text] [Related]

  • 14. [Recent regimen of chemotherapy for advanced head and neck carcinomas].
    Tsukuda M.
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):341-7. PubMed ID: 10740626
    [Abstract] [Full Text] [Related]

  • 15. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    Soulières D, Faivre S, Mesía R, Remenár É, Li SH, Karpenko A, Dechaphunkul A, Ochsenreither S, Kiss LA, Lin JC, Nagarkar R, Tamás L, Kim SB, Erfán J, Alyasova A, Kasper S, Barone C, Turri S, Chakravartty A, Chol M, Aimone P, Hirawat S, Licitra L.
    Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
    Sampath D, Greenberger LM, Beyer C, Hari M, Liu H, Baxter M, Yang S, Rios C, Discafani C.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3459-69. PubMed ID: 16740771
    [Abstract] [Full Text] [Related]

  • 19. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Awada A, Ismael G.
    Curr Opin Oncol; 2007 May 01; 19(3):177-9. PubMed ID: 17414633
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.